Investigational Nasal Aerosol in Children with Perennial Allergic Rhinitis
- Study Title
- Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Female, Maleergic Rhinitis (PAR)
- Teva Identifier
- BDP-AR-306
- ClinicalTrials.gov Identifier
- NCT01783548
- Study Status
- Completed
- Trial Condition(s)
- Female, Maleergic Rhinitis
- Interventions
- Drug: BDP Nasal Aerosol | Drug: Placebo
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child
- Age Range
- 4 Years to 11 Years
- Trial Duration
- 01/01/2013 - 10/01/2013
- Phase
- Phase 3